- Home
- DYN vs BFH Comparison
DYN vs BFH Comparison
Compare DYN & BFH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DYN | BFH |
|---|---|---|
| Founded | 1984 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 3.7B |
| IPO Year | 2020 | 2000 |
Fundamental Metrics
Financial Performance| Metric | DYN | BFH |
|---|---|---|
| Price | $24.07 | $97.93 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 14 | 15 |
| Target Price | $37.00 | ★ $80.64 |
| AVG Volume (30 Days) | ★ 2.4M | 728.6K |
| Earning Date | 05-04-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 1.08% |
| EPS Growth | N/A | ★ 98.36 |
| EPS | N/A | ★ 4.15 |
| Revenue | N/A | ★ $4,521,400,000.00 |
| Revenue This Year | N/A | $53.25 |
| Revenue Next Year | N/A | $3.53 |
| P/E Ratio | ★ N/A | $23.34 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.64 | $53.90 |
| 52 Week High | $25.00 | $109.91 |
Technical Indicators
Market Signals| Indicator | DYN | BFH |
|---|---|---|
| Relative Strength Index (RSI) | 69.01 | 48.67 |
| Support Level | $16.47 | $68.65 |
| Resistance Level | $24.48 | $99.13 |
| Average True Range (ATR) | 1.22 | 3.59 |
| MACD | 0.17 | -1.48 |
| Stochastic Oscillator | 87.59 | 37.27 |
Price Performance
Historical ComparisonAbout DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
About BFH Bread Financial Holdings Inc.
Formed by a combination of JCPenney's credit card processing unit and The Limited's credit card bank business, Bread Financial is a provider of private-label and co-branded credit cards, loyalty programs, and marketing services. The company's most financially significant unit is its credit card business that partners with retailers to jointly market Bread's credit cards to their customers. The company also retains a minority interest in spun-off LoyaltyOne, which operates the largest airline miles loyalty program in Canada and offers marketing services to grocery chains in Europe and Asia.